Trial Profile
A Phase I, Double-blind, Placebo-controlled, Single Oral Dose, Safety, Tolerability, and Pharmacokinetic Study, Incorporating an Evaluation of the Effect of Food on the Pharmacokinetics of HEC68498 in Healthy Male and Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 May 2021
Price :
$35
*
At a glance
- Drugs HEC-68498 (Primary)
- Indications Idiopathic pulmonary fibrosis; Solid tumours
- Focus Adverse reactions
- Sponsors Sunshine Lake Pharma
- 05 May 2021 Status changed from active, no longer recruiting to completed.
- 17 Mar 2021 Planned End Date changed from 4 Mar 2019 to 4 Mar 2022.
- 17 Mar 2021 Status changed from recruiting to active, no longer recruiting.